Back to Journals » Clinical Ophthalmology » Volume 13

Challenges to detect glaucomatous visual field loss with pupil perimetry [Corrigendum]

Authors Asakawa K, Shoji N 

Received 30 August 2019

Accepted for publication 30 August 2019

Published 6 September 2019 Volume 2019:13 Pages 1749—1750

DOI https://doi.org/10.2147/OPTH.S229280




Asakawa K and Shoji N. Clin Ophthalmol. 2019;13:1621–1625.

On page 1622, 3rd paragraph from the left hand column, the sentence “Based on our previous study,8 in the 36 test points, the sensitivity of the seventh highest point when compared with the normal value was used as the standard degree of sensitivity for the entire visual field. The pattern deviation (85th percentile) of the pupil field was calculated as a value representing the difference between age-matched normal and abnormal percentage pupil constriction.” should read “Based on our previous study,8 in the 36 test points, the sensitivity of the fifth highest point when compared with the normal value was used as the standard degree of sensitivity for the entire visual field. The pattern deviation (85th percentile) of the pupil field was calculated as a value representing the difference between age-matched normal and abnormal percentage pupil constriction.” 

Following a review of our data post-publication, we found the incorrect calculation for the 36 test points with the 85th percentile value of pupil perimetry which should read fifth highest point instead.

In the 36 points, the 85th percentile value of pupil perimetry was calculated as follows:
36×0.85=30.6
36−30.6=5.4
The authors apologize for this error.

 

Read the original article 

Creative Commons License © 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.